MedPath

Aerobic Interval Training in Patients With Atrial Fibrillation

Not Applicable
Completed
Conditions
Atrial Fibrillation
Interventions
Behavioral: Interval training
Registration Number
NCT01325675
Lead Sponsor
Norwegian University of Science and Technology
Brief Summary

The purpose of this study is to determine the effect of aerobic interval training in patients with paroxysmal or persistent atrial fibrillation, especially to see if the burden of atrial fibrillation and symptoms are reduced.

Detailed Description

Long term endurance sport practice is associated with a higher incidence of atrial fibrillation. Moderate/light physical activity seems to be associated with a lower incidence. The underlying mechanisms are uncertain. In order to examine the effect of training in this population, the investigators will perform a randomised controlled study with aerobic interval training in patients with paroxysmal/persistent atrial fibrillation.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
51
Inclusion Criteria
  • Patients with paroxysmal or persistent atrial fibrillation, that are able to perform aerobic interval training.
Exclusion Criteria
  • Performing high intensity training (pulse >90% of max) for more than 2 times a week.
  • Moderate intensity training more than 30 min, more than 3 times a week
  • Previous open heart surgery
  • EF <40%
  • Significant aorta stenosis
  • Mitral insufficiency, >gr. 2
  • Pacemaker
  • Earlier coronary intervention and not complete revascularization

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Interval trainingInterval trainingInterval training
Primary Outcome Measures
NameTimeMethod
Change in burden of atrial fibrillationBaseline and 4 weeks after ended intervention period

Burden of atrial fibrillation(number of episodes, duration(percent of the day)) continually measured, and reported by the patient. Analysed for the patients in total, with sub analysis in the groups of paroxysmal and persistent AF and in those with a low burden of atrial fibrillation vs. those with a larger burden.

Secondary Outcome Measures
NameTimeMethod
Endothelial functionBaseline and after ended intervention period(12 weeks)

FMD

Atrial extrasystolesBaseline and after ended intervention period(12 weeks)

Atrial extrasystoles on 48h Holter monitoring. Will alse be measured in the first week of training.

Ablation procedureMeasured during the ablation procedure (day 1)

Duration of ablation, number of ablation points, success.

Maximal oxygen uptakeBaseline and after ended intervention period(12 weeks)
Atrial and ventricular functionBaseline and after ended intervention period(12 weeks)

Atrial and ventricular function measured by MR and echocardiography

FibrosisBaseline and after ended intervention period(12 weeks)

Fibrosis in left atrium and left ventricle measured by MRI.

Quality of lifeBaseline and after ended intervention period(12 weeks)

Measured with SF-36, Symptom and Severity Checklist and EHRA score of AF- related symptoms

Burden of atrial fibrillation in the intervention periodWeek 1-4, 5-8 and 9-12

The intervention period is divided into 3 periods of 4 weeks each. The mean burden of atrial fibrillation(percent of time with atrial fibrillation) and number of episodes in each of those periods will be assessed to see if exercise changes the amount of fibrillation.

Size of left atrium and ventricleBaseline and after ended intervention period(12 weeks)

Atrial and ventricular size will be evaluated by echocardiography and MRI.

Blood samplesBaseline and after ended intervention period(12 weeks)

Interleukin-6, pro-BNP, d-dimer and von Willenbrands factor are measured.

Trial Locations

Locations (1)

Norwegian University of Science and Technology

🇳🇴

Trondheim, Norway

© Copyright 2025. All Rights Reserved by MedPath